Optimizing the immunosuppressive regimen in heart transplantation
- 31 May 2004
- journal article
- review article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (5) , S207-S213
- https://doi.org/10.1016/j.healun.2004.03.010
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report—2003The Journal of Heart and Lung Transplantation, 2003
- NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1Transplantation, 2003
- Cardiac allograft vasculopathy:Transplantation Proceedings, 2002
- Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imagingThe American Journal of Cardiology, 2002
- The role of certican (everolimus, rad) in the many pathways of chronic rejectionTransplantation Proceedings, 2001
- What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?Trials, 2000
- The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Report—2000The Journal of Heart and Lung Transplantation, 2000
- INCIDENCE, PROGRESSION AND FUNCTIONAL SIGNIFICANCE OF CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION1Transplantation, 2000
- Allograft VasculopathyCirculation, 1999
- Post-transplant hyperlipidaemiaPostgraduate Medical Journal, 1997